[go: up one dir, main page]

AU2003275433A8 - Compositions and methods for treating pain - Google Patents

Compositions and methods for treating pain

Info

Publication number
AU2003275433A8
AU2003275433A8 AU2003275433A AU2003275433A AU2003275433A8 AU 2003275433 A8 AU2003275433 A8 AU 2003275433A8 AU 2003275433 A AU2003275433 A AU 2003275433A AU 2003275433 A AU2003275433 A AU 2003275433A AU 2003275433 A8 AU2003275433 A8 AU 2003275433A8
Authority
AU
Australia
Prior art keywords
compositions
methods
treating pain
pain
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275433A
Other versions
AU2003275433A1 (en
Inventor
Stephen J Peroutka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synergia Pharma Inc
Original Assignee
Synergia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergia Pharma Inc filed Critical Synergia Pharma Inc
Publication of AU2003275433A1 publication Critical patent/AU2003275433A1/en
Publication of AU2003275433A8 publication Critical patent/AU2003275433A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003275433A 2002-10-07 2003-10-06 Compositions and methods for treating pain Abandoned AU2003275433A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41626802P 2002-10-07 2002-10-07
US60/416,268 2002-10-07
PCT/US2003/031481 WO2004032844A2 (en) 2002-10-07 2003-10-06 Compositions and methods for treating pain

Publications (2)

Publication Number Publication Date
AU2003275433A1 AU2003275433A1 (en) 2004-05-04
AU2003275433A8 true AU2003275433A8 (en) 2004-05-04

Family

ID=32093834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275433A Abandoned AU2003275433A1 (en) 2002-10-07 2003-10-06 Compositions and methods for treating pain

Country Status (2)

Country Link
AU (1) AU2003275433A1 (en)
WO (1) WO2004032844A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
JP2008514612A (en) * 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー Methods of modulating neurotransmitter systems by inducing counter adaptation
NZ579368A (en) 2007-03-09 2012-03-30 Chelsea Therapeutics Inc Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia
EP2514417A3 (en) 2007-05-07 2013-01-30 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
JP5880913B2 (en) 2011-05-17 2016-03-09 三郎 佐古田 Treatment for trunk symptoms (postural reflex abnormalities) in Parkinson's disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3559572B2 (en) * 1993-01-29 2004-09-02 住友製薬株式会社 Analgesics for acute and chronic pain

Also Published As

Publication number Publication date
WO2004032844A2 (en) 2004-04-22
AU2003275433A1 (en) 2004-05-04
WO2004032844A3 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
GB2423928B (en) Methods and compositions for treating pain
IL160388A0 (en) Topical compositions and methods for treating pain
IL172194A0 (en) Methods and compositions for treating amyloid-related diseases
ZA200409332B (en) Novel methods and compositions for alleviating pain
GB2421434B (en) Compositions And Methods For Treating Gynaecological Disorders
GB0110288D0 (en) Composition and treatment method
AU2003287443A8 (en) Compositions and methods for pain reduction
EP1613266A4 (en) Methods of treating pain and compositions for use therefor
EP1468118A4 (en) Methods and compositions for treating cancer
GB0609689D0 (en) Non-nucleotide compositions and method for treating pain
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
AU2003268032A8 (en) Composition and methods for treatment and screening
AU2003297573A8 (en) Compositions and methods for treating transplants
AU2003232044A8 (en) Composition and method for dermatological treatment
AU2003211009A8 (en) Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
GB0303609D0 (en) Novel therapeutic method and compositions
EP1461047A4 (en) Compositions and methods for animal treatment
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003275433A8 (en) Compositions and methods for treating pain
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
GB0303600D0 (en) Novel therapeutic method and compositions
IL148924A0 (en) Compositions and methods for treating and preventing necrosis
IL163878A0 (en) Compositions and methods for treating mdma-inducedtoxicity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase